Sébastien Corre

9PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursEvolutionary impacts of climate changeGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 24, 2026
AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.

Cyrille Berra, Héloïse M Leclair, Anthony Sebillot

|Dec 05, 2025
CD9, a tetraspanin in cancer: biology and therapeutic promise in acute leukemia.

Océane Guého, Elie Cousin, Jérémie Rouger-Gaudichon

|Oct 28, 2022
The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma.

Anaïs Paris, Nina Tardif, Francesca M Baietti

|Jan 21, 2022
Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets.

Anais Prouteau, Stephanie Mottier, Aline Primot

|Mar 16, 2021
CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and resistance.

Arthur Gautron, Laura Bachelot, Marc Aubry

|Jan 16, 2021
AhR and Cancer: From Gene Profiling to Targeted Therapy.

Anaïs Paris, Nina Tardif, Marie-Dominique Galibert

Pageof 2

Frequent Collaborators

5 joint publications

Marie-Dominique Galibert

3 joint publications

Nina Tardif

3 joint publications

David Gilot

3 joint publications

Eleonora Leucci